SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950162-07-000033
Filing Date
2007-01-12
Accepted
2007-01-12 16:01:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA/CLAUDIO CAVAZZA - SCHEDULE 13G - 01/03/07 dorclaudio13g_010307.htm SC 13G 334733
  Complete submission text file 0000950162-07-000033.txt   336578
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 07528827
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 ROME ITALY L6 00000
Business Address
CAVAZZA CLAUDIO (Filed by) CIK: 0001164803 (see all company filings)

Type: SC 13G